Literature DB >> 16160734

Exogenous PTH-related protein and PTH improve mineral and skeletal status in 25-hydroxyvitamin D-1alpha-hydroxylase and PTH double knockout mice.

Yingben Xue1, Zengli Zhang, Andrew C Karaplis, Geoffrey N Hendy, David Goltzman, Dengshun Miao.   

Abstract

UNLABELLED: We examined the effect of NH2-terminal fragments of PTHrP and PTH in young mutant mice deficient in both PTH and 1,25-dihydroxyvitamin D. Both proteins prolonged murine survival by increasing serum calcium, apparently by enhancing renal calcium transporter expression. The dominant effect on the skeleton was an increase in both endochondral bone and appositional formation without increased bone resorption.
INTRODUCTION: PTH-related protein (PTHrP) was discovered as a hypercalcemic agent responsible for the syndrome of humeral hypercalcemia of malignancy, and PTH is the major protein hormone regulating calcium homeostasis. Both proteins have skeletal anabolic actions when administered intermittently. We examined effects of exogenous PTHrP(1-86) and PTH(1-34) in double null mutant mice deficient in both PTH and 25-hydroxyvitamin D-1alpha-hydroxylase [1alpha(OH)ase] to determine the action of these proteins in the absence of the two major regulators of calcium and skeletal homeostasis.
MATERIALS AND METHODS: Mice heterozygous for the PTH null allele and for the 1alpha(OH)ase null allele were mated to generate pups homozygous for both null alleles. PTHrP(1-86) and PTH(1-34) were administered subcutaneously starting 4 days after birth. Serum biochemistry and skeletal radiology, histology, and histomorphometry were performed, and indices of bone formation, resorption, and renal calcium transport were determined by real time RT-PCR, Western blot, and immunohistochemical approaches.
RESULTS: In the double mutant mice, which die within 3 weeks after birth with severe hypocalcemia, tetany, and skeletal defects, exogenous PTHrP and PTH enhanced survival of the animals by improving serum calcium. Both proteins increased renal calcium transporter expression and long bone length and augmented growth plate chondrocyte proliferation, differentiation, and cartilage matrix mineralization. Cortical and trabecular bone mass was increased with augmented osteoblast number and activity; however, bone resorption was not increased.
CONCLUSIONS: PTHrP and PTH reduced hypocalcemia by enhancing renal calcium reabsorption but not by increasing bone resorption. The major skeletal effects of exogenous PTHrP and PTH were to increase bone anabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160734     DOI: 10.1359/JBMR.050608

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  17 in total

1.  PTHrP 1-141 and 1-86 increase in vitro bone formation.

Authors:  Blake Eason Hildreth; Jillian L Werbeck; Nandu K Thudi; Xiyun Deng; Thomas J Rosol; Ramiro E Toribio
Journal:  J Surg Res       Date:  2010-03-16       Impact factor: 2.192

2.  The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice.

Authors:  Yingben Xue; Yongjun Xiao; Jingning Liu; Andrew C Karaplis; Martin R Pollak; Edward M Brown; Dengshun Miao; David Goltzman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-24       Impact factor: 4.310

3.  PTHrP treatment fails to rescue bone defects caused by Hedgehog pathway inhibition in young mice.

Authors:  Jillian L Brechbiel; Jessica M Y Ng; Tom Curran
Journal:  Toxicol Pathol       Date:  2011-03-16       Impact factor: 1.902

4.  A soluble bone morphogenetic protein type 1A receptor fusion protein treatment prevents glucocorticoid-Induced bone loss in mice.

Authors:  Qinghe Geng; Ke Heng; Jie Li; Shen Wang; Huabei Sun; Liangwei Sha; Yilong Guo; Xinfa Nie; Qingjun Wang; Lei Dai; Xianzhong Zhu; Jiujie Kang; Liwu Shao; Juan Zhai; Sheng Miao; Qiang Lin; Kaijin Guo; Jin Wang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

5.  Quantification of skeletal growth, modeling, and remodeling by in vivo micro computed tomography.

Authors:  Allison R Altman; Wei-Ju Tseng; Chantal M J de Bakker; Abhishek Chandra; Shenghui Lan; Beom Kang Huh; Shiming Luo; Mary B Leonard; Ling Qin; X Sherry Liu
Journal:  Bone       Date:  2015-08-06       Impact factor: 4.398

Review 6.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

7.  Treatment with soluble bone morphogenetic protein type 1A receptor fusion protein alleviates irradiation-induced bone loss in mice through increased bone formation and reduced bone resorption.

Authors:  Shen Wang; Jie Li; Huabei Sun; Liangwei Sha; Yilong Guo; Guanqiu Gu; Jiling Mao; Xinfa Nie; Ying Zhai; Dehong Yu; Juan Zhai; Hongnian Li; Xin Shan; Chengbai Dai; Xiangzhi Wu; Xiaobo He; Li Xin; Jun Liu; Ke Heng; Qinghe Geng
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

8.  The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonates.

Authors:  Lei Shu; Ji Ji; Qi Zhu; Guofan Cao; Andrew Karaplis; Martin R Pollak; Edward Brown; David Goltzman; Dengshun Miao
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

9.  Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.

Authors:  Yuxu Feng; Min Zhou; Qunhu Zhang; Huan Liu; Yong Xu; Lei Shu; Jue Zhang; Dengshun Miao; Yongxin Ren
Journal:  Br J Nutr       Date:  2015-03-06       Impact factor: 3.718

10.  Recombinant human parathyroid hormone related protein 1-34 and 1-84 and their roles in osteoporosis treatment.

Authors:  Hua Wang; Jingning Liu; Ying Yin; Jun Wu; Zilu Wang; Dengshun Miao; Wen Sun
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.